NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
ID: 353105Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $700K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353105

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-24-002.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering the Directors Pioneer Award Program (DP1 Clinical Trial Optional), a federal grant aimed at supporting innovative scientists proposing bold research projects with significant potential impacts on human health. This program encourages applications from a diverse pool of researchers, including those from underrepresented groups and various eligible institutions, to foster groundbreaking ideas across all areas relevant to the NIH mission. Each selected investigator will receive an award budget of up to $700,000 per year for five years, totaling approximately $8 million for FY 2025, with applications due by September 9, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's announcement page at https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-24-002.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-RM-24-002-Full-Announcement.html
    RFA-RM-24-002.html
    The NIH Director’s Pioneer Award Program supports innovative scientists proposing bold research with potential for significant impact on human health. This NOFO emphasizes fostering a diverse researcher pool, encouraging applications from various backgrounds and institutions. The program is open to all research areas relevant to NIH's mission, and applications should reflect groundbreaking ideas distinct from existing research. Each selected investigator must commit substantial effort to the project, with an award budget of $700,000 per year for five years, totaling approximately $8 million for FY 2025. The application process requires strict adherence to guidelines, with deadlines set for submission, and encompasses robust review criteria focused on scientific innovation and the investigator's capability. Letters of reference are required to substantiate claims of innovativeness. The program is part of the High-Risk, High-Reward Research framework, promoting transformative investigations despite inherent risks. Overall, the initiative aims to yield breakthroughs by supporting exceptional creativity in science while prioritizing inclusivity and rigorous evaluation processes.
    Similar Opportunities
    NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIAID New Innovators Awards (DP2), a federal grant aimed at supporting exceptionally creative postdoctoral and early-stage investigators in biomedical research. This funding opportunity encourages innovative research proposals that challenge existing paradigms and may lead to significant advances in the fields of infectious, immunologic, and allergic diseases. Eligible applicants can request up to $300,000 in direct costs per year for a maximum of five years, with the application period open from September 13, 2023, to October 11, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-198.html.
    NCI Outstanding Investigator Award (R35 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NCI Outstanding Investigator Award (R35), aimed at providing long-term support for exceptional cancer research projects. This grant opportunity is designed for accomplished investigators with a proven track record in cancer research, allowing them to pursue innovative and high-risk projects that could lead to significant advancements in the field. The award offers up to $600,000 in direct costs per year for a maximum duration of seven years, with applications due by November 7, 2024. Interested applicants can find more information and contact details at the provided link: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-045.html.
    Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the "Small Grants for New Investigators to Promote Diversity in Health-Related Research" (R21 Clinical Trial Optional) to support new investigators from diverse backgrounds in conducting small research projects. This funding opportunity aims to facilitate the transition to independent research careers for individuals who have not previously secured over $125,000 in direct costs of research funding, specifically targeting those from historically underrepresented groups in biomedical research. The grants, which can last up to three years with a maximum direct cost of $125,000 annually, are intended to foster innovation and address health disparities in underserved populations. Interested applicants must submit their proposals by January 8, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award (K99/R00), a federal grant aimed at facilitating the transition of postdoctoral researchers into independent faculty positions. This program provides up to five years of support through two phases: the K99 phase offers up to two years of mentored training and research, while the R00 phase provides up to three years of independent research funding, contingent upon satisfactory progress and appointment to a qualifying faculty position. The initiative emphasizes the development of a diverse pool of skilled scientists and requires applicants to propose a significant research plan, establish a solid mentorship framework, and demonstrate institutional commitment to their career development. Interested applicants must submit their proposals by May 7, 2027, and can find additional information at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award (K99/R00), a federal grant aimed at supporting postdoctoral researchers in their transition to independent faculty positions. This program is designed to provide up to five years of funding, divided into two phases: the K99 phase for mentored training and the R00 phase for independent research, specifically targeting individuals with no more than four years of postdoctoral experience. The initiative emphasizes the importance of cultivating a diverse and skilled workforce in biomedical and clinical research, encouraging applications from underrepresented groups. Interested applicants must submit their proposals by May 7, 2027, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)" aimed at supporting independent research projects that enhance workforce diversity in health-related sciences. This initiative specifically targets Early Stage and New Investigators from diverse backgrounds, particularly those underrepresented in biomedical, clinical, and social sciences, and does not require preliminary data for application submissions. The NIH intends to commit $2.7 million to this program, with individual awards capped at $500,000 per year for a maximum duration of five years. Interested applicants can find more information and application details at the NIH grants website, and they must submit their applications by February 6, 2025, with the application submission opening on January 28, 2024.
    NIAID and NIDDK Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NIAID and NIDDK Research Opportunities for New and 'At-Risk' Investigators to Promote Workforce Diversity," aimed at enhancing diversity within the biomedical and public health research sectors. This grant supports research projects from New Investigators—those who have not previously secured substantial independent NIH funding—and At-Risk Investigators, who face potential funding loss, particularly from underrepresented backgrounds in health-related sciences. The initiative emphasizes the importance of diverse perspectives in addressing health disparities and requires applicants to demonstrate a commitment to diversity, equity, inclusion, and accessibility in their proposals. Applications are open until September 7, 2025, with no budget limits specified, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-275.html.
    NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award (K99/R00), a federal grant aimed at supporting exceptional postdoctoral researchers in their transition to independent faculty positions while conducting basic experimental studies involving human subjects. This program is designed to facilitate a timely shift from mentored postdoctoral roles to independent research careers, providing funding for up to five years, divided into a mentored K99 phase (up to two years) and an independent R00 phase (up to three years), contingent upon successful transition to tenure-track or equivalent positions. Eligible applicants include a diverse range of institutions, such as Historically Black Colleges and Universities and Tribal Colleges, with key application deadlines starting May 10, 2024, and the final submission date set for May 7, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage for additional details.
    NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity, aimed at supporting innovative research that addresses disparities in substance use among underserved racial and ethnic minority groups in the U.S. This initiative invites applications from early career or established scholars who propose high-impact projects that challenge existing paradigms and foster community engagement to tackle systemic factors impacting health disparities. With a funding commitment of approximately $2 million annually for 2-3 awards, applicants can request up to $700,000 in direct costs per year for a maximum project period of five years. Interested applicants should submit their proposals by November 14, 2024, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov. For more details, visit the official announcement at http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-026.html.
    NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Medical Scientist Partnership Program (MSPP), a federal grant aimed at developing a diverse pool of predoctoral students pursuing combined doctoral degrees (e.g., M.D./Ph.D.) within the NIH Intramural Research Program. The program seeks to provide rigorous training in biomedical sciences, emphasizing research study design, critical thinking, and professional development, with participants receiving mentorship and networking opportunities to prepare them for leadership roles in biomedical careers. This initiative is crucial for enhancing the biomedical workforce by cultivating clinician-scientists equipped with essential skills, with applications due by August 8, 2025. Interested applicants can find more information and application guidelines at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov.